128 related articles for article (PubMed ID: 7430160)
21. Structure-function relationships in glucagon: properties of highly purified des-His-1-, monoiodo-, and (des-Asn-28, Thr-29)(homoserine lactone-27)-glucagon.
Lin MC; Wright DE; Hruby VJ; Rodbell M
Biochemistry; 1975 Apr; 14(8):1559-63. PubMed ID: 164891
[TBL] [Abstract][Full Text] [Related]
22. Structure-function relationships in glucagon. Re-evaluation of glucagon-(1-21).
Frandsen EK; Thim L; Moody AJ; Markussen J
J Biol Chem; 1985 Jun; 260(12):7581-4. PubMed ID: 2987259
[TBL] [Abstract][Full Text] [Related]
23. New glucagon analogues with conformational restrictions and altered amphiphilicity: effects on binding, adenylate cyclase and glycogenolytic activities.
Hruby VJ; Gysin B; Trivedi D; Johnson DG
Life Sci; 1993; 52(10):845-55. PubMed ID: 8445980
[TBL] [Abstract][Full Text] [Related]
24. N-ethylmaleimide uncouples the glucagon receptor from the regulatory component of adenylyl cyclase.
Lipson KE; Kolhatkar AA; Dorato A; Donner DB
Biochemistry; 1986 Sep; 25(19):5678-85. PubMed ID: 3022802
[TBL] [Abstract][Full Text] [Related]
25. The hepatic adenylate cyclase system. I. Evidence for transition states and structural requirements for guanine nucloetide activiation.
Salomon Y; Lin MC; Londos C; Rendell M; Rodbell M
J Biol Chem; 1975 Jun; 250(11):4239-45. PubMed ID: 1126949
[TBL] [Abstract][Full Text] [Related]
26. Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase.
Krstenansky JL; Trivedi D; Hruby VJ
Biochemistry; 1986 Jul; 25(13):3833-9. PubMed ID: 3017406
[TBL] [Abstract][Full Text] [Related]
27. A reassessment of structure-function relationships in glucagon. Glucagon1-21 is a full agonist.
Wright DE; Hruby VJ; Rodbell M
J Biol Chem; 1978 Sep; 253(18):6338-40. PubMed ID: 210180
[TBL] [Abstract][Full Text] [Related]
28. Glucagon antagonists. Synthesis and inhibitory properties of Asp3-containing glucagon analogs.
Andreu D; Merrifield RB
Eur J Biochem; 1987 May; 164(3):585-90. PubMed ID: 3032623
[TBL] [Abstract][Full Text] [Related]
29. Characterization of glucagon receptors in Golgi fractions of rat liver: evidence for receptors that are uncoupled from adenylyl cyclase.
Lipson KE; Kolhatkar AA; Cherksey BD; Donner DB
Biochemistry; 1986 May; 25(9):2612-20. PubMed ID: 3013309
[TBL] [Abstract][Full Text] [Related]
30. The lipid environment of the glucagon receptor regulates adenylate cyclase activity.
Houslay MD; Hesketh TR; Smith GA; Warren GB; Metcalfe JC
Biochim Biophys Acta; 1976 Jun; 436(2):495-504. PubMed ID: 179599
[TBL] [Abstract][Full Text] [Related]
31. Preparation and properties of glucagon analogs prepared by semi-synthesis from CNBr-glucagon.
Wright DE; Hruby VJ; Rodbell M
Biochim Biophys Acta; 1980 Aug; 631(1):49-58. PubMed ID: 6249392
[TBL] [Abstract][Full Text] [Related]
32. Solubilization and separation of the glucagon receptor and adenylate cyclase in guanine nucleotide-sensitive states.
Welton AF; Lad PM; Newby AC; Yamamura H; Nicosia S; Rodbell M
J Biol Chem; 1977 Sep; 252(17):5947-50. PubMed ID: 197078
[TBL] [Abstract][Full Text] [Related]
33. Re-evaluation of glucagon1-6: the N-terminal hexapeptide of glucagon is not biologically active in the hepatic adenylate cyclase system.
Pelton JT; Trivedi D; Hruby VJ
Life Sci; 1983 Sep; 33(13):1307-14. PubMed ID: 6888179
[TBL] [Abstract][Full Text] [Related]
34. Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects.
Livingston JN; Einarsson K; Backman L; Ewerth S; Arner P
J Clin Invest; 1985 Feb; 75(2):397-403. PubMed ID: 2982913
[TBL] [Abstract][Full Text] [Related]
35. Effects of GTP on binding of (3H) glucagon to receptors in rat hepatic plasma membranes.
Lin MC; Nicosia S; Lad PM; Rodbell M
J Biol Chem; 1977 Apr; 252(8):2790-2. PubMed ID: 16000
[TBL] [Abstract][Full Text] [Related]
36. The hepatic glucagon receptor: a comparative study of the regulatory and structural properties.
Padrell E; Herberg JT; Monsatirsky B; Floyd G; Premont RT; Iyengar R
Endocrinology; 1987 Jun; 120(6):2316-25. PubMed ID: 3032585
[TBL] [Abstract][Full Text] [Related]
37. The glucagon receptor from liver can be functionally fused to caudate nucleus adenylate cyclase.
Tolkovsky AM; Martin BR
FEBS Lett; 1982 Dec; 150(2):337-42. PubMed ID: 6297980
[No Abstract] [Full Text] [Related]
38. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
[TBL] [Abstract][Full Text] [Related]
39. Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes.
Robberecht P; Waelbroeck M; De Neef P; Camus JC; Gourlet P; Christophe J
Life Sci; 1988; 42(5):505-10. PubMed ID: 2828794
[TBL] [Abstract][Full Text] [Related]
40. The relation of predicted structure to observed conformation and activity of glucagon analogs containing replacements at positions 19, 22, and 23.
Murphy J; Zhang WJ; Macaulay W; Fasman G; Merrifield RB
J Biol Chem; 1987 Dec; 262(36):17304-12. PubMed ID: 3693354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
